0001401708-24-000086.txt : 20240508
0001401708-24-000086.hdr.sgml : 20240508
20240508204822
ACCESSION NUMBER: 0001401708-24-000086
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240506
FILED AS OF DATE: 20240508
DATE AS OF CHANGE: 20240508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Garland Jonathan Todd
CENTRAL INDEX KEY: 0001924824
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35980
FILM NUMBER: 24928164
MAIL ADDRESS:
STREET 1: C/O CYTEK BIOSCIENCES, INC.
STREET 2: 47215 LAKEVIEW BOULEVARD
CITY: FREMONT
STATE: CA
ZIP: 94538
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NanoString Technologies Inc
CENTRAL INDEX KEY: 0001401708
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 200094687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-378-6266
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
wk-form4_1715215692.xml
FORM 4
X0508
4
2024-05-06
1
0001401708
NanoString Technologies Inc
NSTG
0001924824
Garland Jonathan Todd
C/O NANOSTRING TECHNOLOGIES, INC.
530 FAIRVIEW AVENUE N
SEATTLE
WA
98109
0
1
0
0
Chief Commercial Officer
0
Common Stock
2024-05-06
4
M
0
200000
0
A
200000
D
Restricted Stock Units
2024-05-06
4
M
0
200000
0
D
Common Stock
200000
0
D
The shares have not been delivered to the reporting person.
Each RSU represents a contingent right to receive one (1) share of Issuer's common stock.
Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a "Change of Control" under the terms of the RSU award agreement, the vesting of the RSUs accelerated.
/s/ Shannon Atchison, Attorney in Fact
2024-05-08